{"schema_version":1,"research_id":"eoa_inverse_innovation_exp06_external_evaluation_20260803","source_assessment_id":"catalytic_pathway_enablement__chemistry_materials:P4:v0","cell_id":"catalytic_pathway_enablement__chemistry_materials","search_queries":["site:epa.gov safer alternatives solvent substitution coatings alternatives assessment official","site:osha.gov solvent substitution industrial hygiene safer chemicals toolkit official","coatings solvent substitution cross functional review EHS formulation case study","chemical alternatives assessment framework solvent substitution decision making National Academies","chemical substitution alternatives assessment workflow multidisciplinary team implementation guide industry official","site:oecd.org substitution chemical alternatives assessment guide stakeholder multidisciplinary","site:echa.europa.eu analysis alternatives substitution plan guidance authorization chemical","chemical substitution organizational barriers cross functional teams industry study","site:bls.gov OEWS chemists occupational health safety specialists median wage 2025","site:microsoft.com power automate pricing premium 2026 official","coatings formulation solvent substitution challenge compatibility solvent role paper","industry chemical alternatives assessment barriers adoption study safer substitution","BLS Occupational Employment and Wage Statistics chemists May 2025","BLS occupational health and safety specialists wages May 2025","Microsoft Power Automate pricing official premium per user","Microsoft Power Apps pricing official premium per user","\"Alternatives assessment and informed substitution\" full text Tickner Jacobs Malloy 2019","site:pmc.ncbi.nlm.nih.gov chemical alternatives assessment substitution multidisciplinary","site:epa.gov \"Chemical Alternatives Assessment\" stakeholder criteria","site:turi.org alternatives assessment guide chemical substitution","\"Alternatives Assessment Frameworks: Research Needs for the Informed Substitution of Hazardous Chemicals\" publication date DOI","site:bls.gov/news.release/ocwage.t01.htm chemists May 2025 wage","site:bls.gov/oes/2025/may/oes192031.htm chemists"],"sources":[{"source_id":"S1","title":"Transitioning to Safer Chemicals: A Toolkit for Employers and Workers","publisher":"U.S. Occupational Safety and Health Administration","url":"https://www.osha.gov/safer-chemicals","source_class":"OFFICIAL_GUIDANCE","publication_date":"2013","accessed_at":"2026-08-03","claims_supported":["Employers and workers are identifiable user classes for informed-substitution processes.","Transitioning to safer chemicals is complex enough to warrant a stepwise chemical-management toolkit.","The toolkit is advisory and does not alter OSHA obligations or confer authorization."]},{"source_id":"S2","title":"Summary of Solvent Substitution Information","publisher":"U.S. Environmental Protection Agency","url":"https://www.epa.gov/system/files/documents/2022-08/TRI_SolventSubstitution.pdf","source_class":"GOVERNMENT_OR_REGULATOR","publication_date":"2022-08","accessed_at":"2026-08-03","claims_supported":["Facilities in 16 sectors reported 116 distinct solvent-substitution combinations.","Reported substitutions were mainly associated with cleaning or coating materials and processes.","Suitable substitution requires holistic evaluation of processes, material inputs, energy requirements, and solvent needs."]},{"source_id":"S3","title":"Design for the Environment Alternatives Assessments","publisher":"U.S. Environmental Protection Agency","url":"https://www.epa.gov/saferchoice/design-environment-alternatives-assessments","source_class":"GOVERNMENT_OR_REGULATOR","publication_date":"2026-01-15","accessed_at":"2026-08-03","claims_supported":["EPA already documents a seven-step alternatives-assessment process covering feasibility, information collection, stakeholder convening, viability, hazard assessment, economic and life-cycle context, and decision use.","Stakeholder interest and participation across manufacturers, users, waste actors, and other life-cycle stages are established components.","EPA records confidence and conflicting or limited evidence rather than treating structural completeness as approval."]},{"source_id":"S4","title":"A Framework to Guide Selection of Chemical Alternatives — Summary","publisher":"National Academies Press via NCBI Bookshelf","url":"https://www.ncbi.nlm.nih.gov/books/NBK253953/","source_class":"AUTHORITATIVE_SECONDARY","publication_date":"2014-10-29","accessed_at":"2026-08-03","claims_supported":["Chemical-alternatives assessment already has an authoritative multidisciplinary framework.","Relevant expertise includes toxicology, chemistry, materials science, exposure, life cycle, engineering, economics, and cost analysis.","Smaller organizations may require user-friendly tools or technical support to apply the framework."]},{"source_id":"S5","title":"Guidance on Key Considerations for the Identification and Selection of Safer Chemical Alternatives","publisher":"Organisation for Economic Co-operation and Development","url":"https://www.oecd.org/content/dam/oecd/en/publications/reports/2021/03/guidance-on-key-considerations-for-the-identification-and-selection-of-safer-chemical-alternatives_142b6915/a1309425-en.pdf","source_class":"OFFICIAL_GUIDANCE","publication_date":"2021","accessed_at":"2026-08-03","claims_supported":["Scoping, documented goals, principles, decision rules, and stakeholder input are established alternatives-assessment practices.","For solvent selection, production, R&D, regulatory, and EHS functions can contribute distinct evidence and identify trade-offs.","Narrower assessments can be more efficient but risk missing trade-offs, supporting explicit eligibility and escalation boundaries."]},{"source_id":"S6","title":"Transitioning to Safer Chemicals — Step 7: Implement and Evaluate the Alternative","publisher":"U.S. Occupational Safety and Health Administration","url":"https://www.osha.gov/safer-chemicals/step7-evaluate","source_class":"OFFICIAL_GUIDANCE","publication_date":"2013","accessed_at":"2026-08-03","claims_supported":["Small-scale testing should precede full-capacity substitution.","Implementation requires documented organizational and technological changes, role assignment, communication, and training.","Post-implementation monitoring should cover health, safety, performance, efficiency, and productivity."]},{"source_id":"S7","title":"Alternatives Assessment Frameworks: Research Needs for the Informed Substitution of Hazardous Chemicals","publisher":"Environmental Health Perspectives; open copy hosted by University of California eScholarship","url":"https://escholarship.org/uc/item/5pb988q7","source_class":"PRIMARY_RESEARCH","publication_date":"2016","accessed_at":"2026-08-03","claims_supported":["A structured review found 20 alternatives-assessment frameworks published from 1990 through 2014.","Frameworks were generally consistent in process steps, substantially limiting the novelty of another structured multidisciplinary pathway.","Persistent gaps include exposure characterization, life-cycle assessment, decision analysis, data gaps, and context-specific implementation; case studies are needed."]},{"source_id":"S8","title":"Table 1. National Employment and Wage Data by Occupation, May 2025","publisher":"U.S. Bureau of Labor Statistics","url":"https://www.bls.gov/news.release/ocwage.t01.htm","source_class":"OFFICIAL_ORGANIZATION_DATA","publication_date":"2026-05-15","accessed_at":"2026-08-03","claims_supported":["May 2025 mean annual wages were approximately $100,450 for chemists, $91,680 for environmental scientists and specialists including health, $93,860 for occupational-health-and-safety specialists, and $119,770 for health-and-safety engineers.","These wage benchmarks support labor-order-of-magnitude estimates but exclude benefits, overhead, software, legal review, and opportunity cost."]}],"problem_evidence":{"support":"MODERATE","rationale":"Solvent substitution is visibly practiced across sectors and is especially associated with coating and cleaning changes; official and authoritative sources show that substitution requires multidisciplinary assessment of hazard, exposure, performance, process, economics, life cycle, and implementation. However, no external source verifies the candidate's facility-specific assertion that complete dossiers repeatedly stall mainly because of evidence reformatting, terminology translation, and meeting coordination rather than missing experiments, incompatible chemistry, unavailable reviewers, or trial-rig capacity.","source_ids":["S1","S2","S4","S5","S7"]},"stakeholder_evidence":{"support":"WEAK","rationale":"OSHA, EPA, OECD, and the National Academies identify employers, workers, manufacturers, EHS functions, regulators, and multidisciplinary assessment teams as users or participants with a general need for informed substitution. No named coatings facility, materials-governance chair, funder, or other candidate-specific adopter was found expressing demand for this evidence-translation lane or committing authority, dossiers, staff time, or funding.","source_ids":["S1","S3","S4","S5"]},"prior_art":{"proximity":"SUBSTANTIAL_COLLISION","closest_analogues":[{"name":"EPA Design for the Environment seven-step alternatives assessment","similarity":"Already scopes an assessment, gathers structured chemical information, convenes lifecycle stakeholders, evaluates viability and hazards, represents uncertainty, adds economic and lifecycle context, and supports a decision.","remaining_difference":"It is a general assessment method, not a facility-level reusable fast lane with automated dossier views, workload metering, reset checks, and a controlled comparison against the existing full-review workflow.","source_ids":["S3"]},{"name":"National Academies chemical-alternatives framework","similarity":"Establishes multidisciplinary expertise, structured assessment, decision support, and implementation considerations for safer chemical substitution.","remaining_difference":"It does not test whether a standing internal translation service can reduce administrative effort while holding evidence, authorities, and substantive criteria constant.","source_ids":["S4"]},{"name":"OECD safer-chemical-alternatives guidance","similarity":"Already calls for bounded scope, stakeholder participation, explicit goals and decision rules, and attention to R&D, regulatory, production, and EHS concerns and trade-offs.","remaining_difference":"It is guidance rather than an instrumented service with eligibility inter-rater testing, capacity limits, case-by-case regeneration, and measured turnover.","source_ids":["S5"]},{"name":"OSHA Transitioning to Safer Chemicals toolkit","similarity":"Provides an employer-facing stepwise workflow, small-scale testing, implementation planning, team communication, training, and continuing evaluation.","remaining_difference":"It concerns the substitution program and implementation outcome, not specifically a nonbinding shadow review lane that translates unchanged evidence for internal functional authorities.","source_ids":["S1","S6"]}],"distinctive_claim_remaining":"For already-complete, objectively eligible single-solvent-substitution dossiers within one authorized coating platform, a reusable translation-and-routing service will reduce median elapsed decision time, handoffs, and total specialist plus requester labor relative to the existing full-review pathway, without increasing omitted criteria, evidence distortion, inappropriate admissions, disagreement, confidentiality incidents, post-decision deviations, hidden preparation work, reviewer overload, or downstream queueing; it will also return to a current, adequately staffed, unconflicted state after each case. This is contrastive and falsifiable but untested.","confidence":"HIGH"},"implementation_evidence":{"support":"MODERATE","rationale":"Official guidance establishes that structured intake, multidisciplinary review, explicit decision rules, small-scale pilots, documented roles, and monitoring are technically and organizationally feasible. A nonbinding shadow workflow can be implemented with existing document and workflow tools and need not make chemical judgments. Feasibility remains unverified for the candidate facility's dossier formats, confidential-business-information controls, reviewer availability, authority map, eligibility reliability, integration burden, exception rate, or capacity to maintain templates and backup stewards.","source_ids":["S3","S4","S5","S6","S7"]},"scores":{"meaningful_impact":{"score":3,"rationale":"If coordination rather than missing science is a material bottleneck, reducing repeated specialist handling could accelerate bounded trial decisions and release scarce expert capacity. The local prevalence and magnitude are unknown.","source_ids":["S2","S4","S5"]},"stakeholder_pull":{"score":2,"rationale":"There is broad official demand for safer-substitution processes, but no candidate-specific adopter, authorizer, budget owner, or expressed request was identified.","source_ids":["S1","S3","S5"]},"incremental_advantage":{"score":2,"rationale":"Templates, routing, completeness checks, and workload visibility plausibly improve an ad hoc process, but the benefit over configuring existing alternatives-assessment practice and ordinary workflow management has not been measured.","source_ids":["S3","S5","S7"]},"distinctiveness_plausibility":{"score":2,"rationale":"The underlying multidisciplinary, scoped, rule-governed, pilot-and-monitor practice substantially collides with established frameworks. Distinctiveness survives only as a local measured workflow-performance and regeneration claim.","source_ids":["S3","S4","S5","S7"]},"technical_implementability":{"score":4,"rationale":"A nonbinding dossier, rules, routing, versioning, audit-log, and dashboard workflow is technically routine. The difficult work is governance, evidence semantics, validation, and maintenance rather than software invention.","source_ids":["S4","S5","S6"]},"adoption_authority_feasibility":{"score":3,"rationale":"Existing functional authorities can remain intact and a governance chair could authorize a shadow exercise, but no real chair, data owner, or required reviewer has agreed to do so.","source_ids":["S1","S3","S6"]},"evidence_readiness":{"score":2,"rationale":"Public sources establish the general field but cannot answer the core claim. The needed closed dossiers, timestamps, reviewer effort, criteria, deviations, access approvals, and authoritative records are proprietary and site-specific.","source_ids":["S3","S7"]},"safety_net_benefit":{"score":3,"rationale":"The proposed nonbinding shadow mode, escalation rules, unchanged authority, audit trail, and stop criteria provide a credible safety net. Misclassification, data exposure, template omissions, and normalization of a fast lane remain material risks.","source_ids":["S3","S5","S6"]},"scalability":{"score":3,"rationale":"A validated template and routing service could process repeated bounded cases, but each coating platform, facility, jurisdiction, waste route, exposure context, and authority structure may require revalidation; specialist and downstream capacity do not scale automatically.","source_ids":["S4","S5","S6"]}},"score_confidence":"MODERATE","costs":{"first_evidence":{"band_2026_usd":"10K_TO_50K","scope":"Manual, nonbinding shadow comparison on up to eight already-closed dossiers: protocol and metric definition, data-access review, dossier masking, two steward passes, criterion-level reviewer comparison, workload capture, analysis, and closeout; excludes new chemical testing and production workflow integration.","confidence":"LOW","assumptions":["Approximately 180-350 combined internal hours across a coordinator, two stewards, required functional reviewers, data governance, and analysis.","Existing secure document storage and meeting tools are available.","Loaded internal labor is inferred above published wage rates and includes benefits and overhead; BLS reports wages, not total employer cost.","Dossiers are already closed and do not require laboratory work."],"source_ids":["S4","S8"]},"initial_deployment_startup":{"band_2026_usd":"50K_TO_250K","scope":"Design and validate the production-grade intake contract, dossier schema, eligibility logic, reviewer views, access controls, audit trail, dashboard, version governance, backup coverage, training, and template-change procedure for one facility and one coating platform.","confidence":"LOW","assumptions":["Roughly 0.5-1.5 full-time-equivalent years distributed across chemistry, EHS, process, waste, workflow configuration, privacy/security, and training.","An existing enterprise workflow platform can be configured rather than procured and integrated from scratch.","No new analytical instruments, laboratory rigs, or chemical evidence generation are included."],"source_ids":["S4","S5","S8"]},"operational_launch":{"band_2026_usd":"50K_TO_250K","scope":"Time-bounded live pilot after separate approval, with parallel authoritative review, quality sampling, incident response, steward and backup coverage, reviewer training, performance analysis, and adoption decision; excludes chemical testing and trial execution costs.","confidence":"LOW","assumptions":["Launch remains limited to a single site, authorized platform, and low case volume.","Existing functional reviewers retain authority and contribute part-time.","Parallel review temporarily duplicates effort and dominates the launch cost."],"source_ids":["S6","S8"]},"annual_recurring":{"band_2026_usd":"50K_TO_250K","scope":"Part-time primary and backup stewardship, workflow administration, periodic access review, template and rule refresh, reviewer calibration, exception audits, monitoring, retraining, and incident handling for one site; excludes scientific testing and downstream trial capacity.","confidence":"LOW","assumptions":["Approximately 0.5-1.5 recurring FTE equivalents distributed among stewards, functional reviewers, workflow support, and governance.","Case volume remains within existing reviewer and trial-rig capacity.","Major regulation, platform, or formulation changes could trigger additional startup-like revalidation."],"source_ids":["S5","S6","S8"]}},"verified_pipeline_gates":{"externally_supported_problem":{"status":"UNCERTAIN","reason":"External evidence strongly supports the complexity and importance of coating-related solvent substitution, but not the asserted local rate-limiting mechanism of repeated translation and coordination for otherwise complete dossiers.","source_ids":["S1","S2","S4","S5"]},"externally_credible_adopter_or_authorizer":{"status":"NO","reason":"Official sources identify plausible adopter classes, but no named facility, materials-governance chair, EHS owner, or funder has expressed need or committed authority and resources for this candidate.","source_ids":["S1","S3","S5"]},"distinct_testable_incremental_claim":{"status":"YES","reason":"The candidate can be compared with the unchanged full-review pathway on elapsed time, handoffs, total visible and hidden labor, criterion preservation, admission errors, confidentiality, deviations, capacity, and reset readiness.","source_ids":["S3","S5","S6"]},"bounded_next_evidence_step":{"status":"YES","reason":"A predeclared, nonbinding shadow study of at most eight closed dossiers is bounded by case count, existing data, no chemical handling, explicit comparators, and hard stop rules.","source_ids":["S5","S6","S7"]},"no_unresolved_safety_or_authority_stop":{"status":"YES","reason":"The bounded next step can remain nonauthoritative, use closed records, require approved access, preserve all existing functional authority, and stop on any criterion, confidentiality, or eligibility failure. This does not establish authority for live use.","source_ids":["S1","S3","S6"]},"credible_cost_scope_and_range":{"status":"YES","reason":"The four scopes exclude laboratory and production work, state staffing and infrastructure assumptions, and use current federal wage data to support broad labor-dominated resource bands, although site-specific estimates remain low-confidence.","source_ids":["S4","S8"]}},"next_evidence_step":"After the facility's data-governance and functional authorities approve access, freeze the intake contract, eligibility rules, protected criteria, effort-accounting method, and analysis plan; then select no more than eight already-closed internal solvent-substitution dossiers before outcomes are unmasked, stratified to include routine-complete, incomplete, and escalation-trigger cases. Two rotating stewards independently run the lane in nonbinding shadow mode. Compare it with reconstruction of the actual full-review pathway while holding evidence, reviewers, criteria, decision authority, and trial scope constant. Measure eligibility agreement, elapsed time, handoffs, requester and specialist hours including preparation and rework, evidence omissions or distortion, criterion preservation, inappropriate admissions, escalation sensitivity, decision and constraint agreement, confidentiality events, conflicts, queue effects, downstream rig capacity, steward workload, and reset work. Falsify the intervention if any protected requirement is weakened or omitted, any ineligible case is fast-tracked, inter-steward eligibility agreement is below 0.8, median total visible-plus-hidden labor does not fall by at least 20%, apparent savings are displaced to unmeasured work, the lane depends on one person, or the template and adequately staffed team cannot return to a verified ready state. Treat evidence that missing experiments, incompatible chemistry, authority delay, or rig capacity dominates total time as falsification of the stated problem mechanism.","blocking_evidence":["No external or site-level evidence quantifies how many otherwise complete solvent-substitution dossiers stall because of translation and handoff work.","No named coatings facility, authorizer, data owner, or funder has expressed demand or committed resources.","No proprietary closed-dossier trace data establish baseline elapsed time, handoffs, visible and hidden labor, exception prevalence, or post-decision deviations.","Eligibility reliability and sensitivity to chemically consequential exceptions have not been measured.","Confidentiality, access-control, retention, and audit requirements for actual formulation and supplier data are unknown.","Reviewer, steward, waste-pathway, analytical, and trial-rig capacities are unknown.","No empirical comparison shows advantage over simply configuring the established alternatives-assessment framework or adding ordinary coordination support.","Cost estimates lack site-specific labor allocation, platform-integration, validation, legal, security, and opportunity-cost data."],"research_disposition":"PARTNERED_RESEARCH_PROGRAM","world_novelty_boundary":"This evaluation measures neither world novelty nor patentability, freedom to operate, market size, or realized impact. The search found substantial established practice in multidisciplinary chemical alternatives assessment, stakeholder-governed scoping, documented decision rules, pilots, and monitoring. It did not establish whether the exact combination of an internal coating-solvent shadow lane, dossier automation, rotating stewardship, capacity metering, and verified post-case regeneration exists elsewhere. The only defensible remaining novelty boundary is the narrow, site-specific empirical claim of lower coordination burden with unchanged criteria and demonstrable facilitator reset.","arm":"COMPLETE_PROPOSAL_PORTFOLIO","candidate_version":0,"controller_recommendation":{"action":"STOP_EMPIRICAL_RESEARCH_NEEDED","repairable":false,"material_progress_observed":true,"progress_targets":["Obtain an explicit written expression of need and shadow-study authorization from a named coatings facility's materials-governance, EHS, industrial-hygiene, waste, process, analytical, and data owners.","Produce a retrospective baseline showing that repeated evidence translation and handoffs, rather than missing science, authorization, or rig capacity, materially drive delay in eligible cases.","Validate the frozen eligibility rule on closed dossiers, including chemically exceptional and incomplete cases, with inter-steward agreement of at least 0.8 and zero inappropriate fast-track admissions in the bounded probe.","Demonstrate at least a 20% reduction in median total visible-plus-hidden labor versus the unchanged full-review comparator without omitted criteria, evidence distortion, confidentiality incidents, additional deviations, reviewer overload, or downstream backlog.","Show that the service can close access, refresh dependencies, resolve conflicts, restore backup coverage, and return to a verified current ready state after every shadow case.","Replace broad resource bands with a site-approved estimate covering internal labor, workflow integration, validation, security, training, opportunity cost, and recurring stewardship."],"reason":"Web evidence establishes a real and important solvent-substitution domain, but also shows substantial collision with mature alternatives-assessment frameworks. The candidate's surviving value proposition is a local workflow-performance claim. Its decisive evidence requires proprietary case traces, named-authorizer participation, confidential-data access, and a live shadow comparison; bounded web research cannot resolve it."},"proposal_index":4}